| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |